Ameya Kulkarni, MD Profile picture
Interventional Cardiologist at MAPMG by day, Health Care Innovator by night, doc wellness in my spare time. and master of the #dadpun. tweets my own.
Mar 14, 2020 11 tweets 8 min read
Lots of talk about the expected surge in ICU and hosp beds with #COVID. I’ve been hearing about reducing elective case burden (great thread from @ajaykirtane about that). We should also be rethinking our hospital approach to conditions that will continue in the covid era 1/n Most obvious is with #STEMI care. If your hospital doesn’t have an ED bypass protocol for stemis - probably a good time to develop one. Ours at @VHC_Hospital has 1 min pitstop in ed w ems txp to cath lab - less pt exposure time to ED and less burden on ED resources 2/n
May 13, 2019 26 tweets 8 min read
Last week, there was renewed interest in the media about maternal mortality. As a guy who helps lead our #cardiacobstetrics prog @MdAtlPermanente I am deeply invested in making maternal mortality as low as possible - b/c a maternal mortality=a kid growing up without a mom. (1/x) So I wanted to understand the data driving the conversation. Boy was I surprised by what I found. Let me tell you why, in a thread (2/x)
Mar 27, 2019 15 tweets 5 min read
Interesting take (both in the article and by @Angiologist about telemed. I have a slightly different view. I work in a system (@MdAtlPermanente @KPMidAtlantic) that uses a lot of virtual care. Not just consults, Also telephone, video, secure messaging, remote monitoring etc. 1/n In fact more than 50% of our patient interactions are non face to face. And here is what we have learned. All of these technologies are just technologies. It is not what they are but how they are used that matters 2/n
Feb 28, 2019 12 tweets 9 min read
Really impressed by the recent #tweetorials by @ADAlthousePhD & @venkmurthy on study design. I was thinking that there are lots of awesome study design methods tweetorials. I'd like to capture them in one place. Here are my favorites. Please add yours (with one line on the topic) @venkmurthy on subgroups in negative trials.